A NEW POSSIBILITY FOR WEIGHT REGULATION?

Scientists are increasingly examining retatrutide, a novel drug created by Eli Lilly, as a potential breakthrough in weight reduction . Different than many previous approaches, retatrutide is a dual -action agonist targeting equally GLP-1 and GIP, substances that affect appetite and blood glucos